VEMLIDY's Impact on Chronic Hepatitis B Treatment Landscape Through 2032
May 03, 2024 05:45 ET
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "VEMLIDY Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report addresses crucial...
Global Hepatitis B Virus Infection Drug Forecast and Market Report 2021-2029: Antisense Nucleotides are Expected to Gain a Market Share of 14.7% and Sales of $761 Million
April 21, 2021 06:28 ET
|
Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Hepatitis B Virus Infection - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The global...
Global Chronic Hepatitis B Virus Market Insight, Epidemiology and Market Forecast Report 2017-2030
October 19, 2020 07:03 ET
|
Research and Markets
Dublin, Oct. 19, 2020 (GLOBE NEWSWIRE) -- The "Chronic Hepatitis B Virus Market Insight, Epidemiology and Market Forecast -2030" drug pipelines has been added to ResearchAndMarkets.com's offering. ...
Global Hepatitis B Market Spotlight 2020: GlaxoSmithKline Leads Industry Sponsors with by Far the Highest Overall Number of Clinical Trials
October 05, 2020 06:59 ET
|
Research and Markets
Dublin, Oct. 05, 2020 (GLOBE NEWSWIRE) -- The "Market Spotlight: Hepatitis B" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Hepatitis B...